(SHM) Nuveen Bloomberg Short Term - NYSE

ETF Category: Muni National Short | Exchange: NYSE (USA) | Market Cap: 3.451m USD | Total Return: 3.1% in 12m

Municipal Bonds, Short Term, Tax Exempt, Investment Grade
Total Rating 42
Safety 60
Buy Signal 0.25
Muni National Short
Category Rotation: -2.8
TER: 0.20%
AUM: 3.45B
Avg Turnover: 7.68M
Risk 3d forecast
Volatility1.27%
VaR 5th Pctl0.22%
VaR vs Median-2.71%
Reward TTM
Sharpe Ratio-0.93
Rel. Str. IBD26.5
Rel. Str. Peer Group35
Character TTM
Beta0.022
Beta Downside-0.006
Hurst Exponent0.621
Drawdowns 3y
Max DD2.03%
CAGR/Max DD1.43
CAGR/Mean DD5.69

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality

Coming soon
Description: SHM Nuveen Bloomberg Short Term

The fund employs a passive indexing strategy, investing at least 80% of its total assets in the securities that make up its underlying index, as well as in securities that the Sub-Adviser considers to have substantially identical economic characteristics. The index itself is rules-based and market-capitalization weighted, specifically engineered for the tax-exempt bond market.

As a short-term municipal bond ETF, SHM targets debt issued by U.S. state and local governments, which typically generates income exempt from federal (and sometimes state) income tax. The short-term designation indicates a shorter duration profile, generally meaning lower sensitivity to interest rate movements compared to longer-dated bond funds.

Headlines to Watch Out For
  • Fed rate cuts compress short-term muni bond yields
  • Money market funds compete with rising tax-equivalent yields
  • Municipal issuance surges on infrastructure spending
What is the price of SHM shares?

As of June 29, 2026, the stock is trading at USD 47.98 with a total of 121,747 shares traded. Over the past week, the price has changed by +0.08%, over one month by +0.62%, over three months by +1.00% and over the past year by +3.10%.

Current recommended Stop Loss: 47.80 (which is 0.4% or 2.6 ATR below the current price).

Is SHM a buy, sell or hold?

Nuveen Bloomberg Short Term has no consensus analysts rating.